BofA Securities analyst Kevin Fischbeck lowered the price target on Elevance (NYSE: ELV) to $350.00 (from $420.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Elevance (ELV) Medicaid margin recovery pushed out to 2027-28 - MizuhoJuly 17, 2025 11:39 AM Form 8-K Elevance Health, Inc. For: Jul 17July 17, 2025 6:04 AM Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS GuidanceJuly 17, 2025 6:02 AM Elevance Health Reports Second Quarter 2025 ResultsJuly 17, 2025 6:00 AM Elevance Health (ELV) July option implied volatility bid into quarter results July 16, 2025 11:18 AM Elevance (ELV) PT Lowered to $440 at Truist SecuritiesJuly 16, 2025 6:59 AM Elevance (ELV) PT Lowered to $400 at Wells FargoJuly 15, 2025 6:00 AM